Clinical Trial Update: Dose Response Effects of Marine Omega-3 Fatty Acids on Inflammation [Phase 3]

View source ↗

Summary

Phase 3 trial examining dose-response effects of marine omega-3 fatty acids on inflammation in cardiovascular disease; completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Cardiovascular Disease with Inflammation

Drugs mentioned

• marine omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Penn State University | Conditions: Cardiovascular Disease, Inflammation | Phase 3 | Status: COMPLETED | Results posted: 2017-06-14